The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is attributed to the the growing industry-academia research collaboations, and increasing number of clinical, forensic and research labs screening will drive the growth of the market.

On the other hand, safety concerns associated with electrophoresis reagents may challenge the growth of market. Whereas, increasing demand for personalized medicines to provide growth opportunities for market.

Electrophoresis Market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.1 billion by 2028, growing at a CAGR of 5.7% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by riding funding for proteomics & genomics research, and growing use of NGS and declining cost of DNA sequencing. Furthermore, growing prominence of nanoproteomics is expected to drive the growth of electrophoresis market. 

The electrophoresis industry is expected to experience significant growth in the near future due to increasing demand for accurate and reliable diagnostic tests. The market is anticipated to witness significant growth due to increasing prevalence of chronic diseases and growing awareness about preventive healthcare.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=434

Browse in-depth TOC on "Electrophoresis Market"

266 - Tables
37 - Figures
292 - Pages

Electrophoresis reagent segment is expected to account for the largest share in 2022.

Electrophoresis is an electrokinetic process that separates charged particles in a fluid using a field of electrical charge. The electrophoresis market, by product, has been segmented into electrophoresis reagents, electrophoresis systems, gel documentation systems and software. Increasing demand for 2D electrophoresis for protein separation for biomarker discovery and protein mapping is expected to drive the electrophoresis market.

Electrophoresis is used in proteomic and genomic research in academic and research institutes. It is also used in the diagnosis of diseases and the quality control of drugs in pharmaceutical and biotechnology companies.

Due to the widespread applications of electrophoresis, market players are collaborating with various academic institutions to increase awareness about new analytical technologies among students and researchers. For instance, In August 2022, SciGenom Labs, a genomics company in India and the US, announced a unique Ph.D. program to support research in genomics, proteomics, microbiome disciplines, and bio-nanotech in collaboration with CHARUSAT University.

Numerous collaborative research projects and similar initiatives have already been launched, and several others are expected to be initiated during the forecast period. Several companies are also helping university researchers by providing technical and financial assistance to commercialize university research projects.

Electrophoresis Market Dynamics:

Drivers:

1.  Rising funding for proteomics and genomics research

2.  Growing industry-academia research collaborations

3.  Growing use of NGS and declining cost of DNA sequencing

4.  Increasing number of clinical, forensic, and research labs

5.  Rising incidence of cancer, infectious diseases, and genetic disorders

6.  Growing prominence of nanoproteomics

Restraints:

1.  Presence of alternative technologies offering better efficiency and results

2.  Time-consuming operations and limited sample analysis

Opportunities:

1.  High growth opportunities in developing countries

2.  Increasing demand for personalized medicines

3.  Shift from plant-based to genome-based drug discovery

Challenges:

1.  Safety concerns associated with electrophoresis reagents

2.  Need for high procedural efficiency to ensure accurate results

Key Market Players:

Major players in electrophoresis market include Bio-Rad Laboratories Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany) and Agilent Technologies, Inc. (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=434

Recent Developments:

  • In 2023, Advanced Electrophoresis Solutions Ltd (Canada) signed Medispec (India) as an exclusive distributor partner in India. This will allow AES' critical solutions to reach many companies located in India.
  • In 2022, Thermo Fisher Scientific (US) introduced a new Applied Biosystems SeqStudio Flex Series Genetic Analyzer to enable customers' cutting-edge research in areas such as gene editing and infectious disease.
  • In 2020, Danaher Corporation (US) acquired GE Healthcare Life Sciences (US) and rebranded it as Cytiva. This company will be a $3.3-billion global life sciences company with nearly 7000 employees in 40 countries.

Electrophoresis Market Advantages:

  • High Sensitivity: Electrophoresis provides very high resolution and sensitivity, allowing for the detection of very small amounts of material.
  • Versatility: Electrophoresis can be used to analyze a variety of molecules, including proteins, nucleic acids, carbohydrates, and lipids.
  • Cost Effective: Electrophoresis is less expensive than other analytical techniques such as mass spectrometry or chromatography.
  • Speed: Electrophoretic separations can be completed relatively quickly, allowing for rapid results.
  • Automation: Electrophoresis can be automated, making it a more efficient and less labor-intensive process.